Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors

Clinical trial NCT02079740 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02079740
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm Unresectable Malignant Solid Neoplasm

Start date: 2014-03-26
Primary completion: 2022-12-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.